ArticleInternational orthopaedics2026
Vascularised fibular graft shoulder arthrodesis after proximal humeral tumour resection with sacrifice of the abductor mechanism.
Article in International orthopaedics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeReconstruction after proximal humeral tumour resection remains challenging when tumour clearance requires sacrifice of the shoulder abductor mechanism. This study evaluated oncological, radiological, functional, and cosmetic outcomes after shoulder arthrodesis using a vascularized fibular graft.
methodsWe retrospectively reviewed 12 patients who underwent proximal humeral tumour resection and shoulder arthrodesis with a vascularized fibular graft between 2019 and 2025. All resections involved the rotator cuff and resulted in loss of the functional deltoid mechanism. Outcomes included oncological status, union, graft hypertrophy, complications, MSTS score, range of motion, functional tasks, cosmetic outcome, and donor-site morbidity.
resultsMean age was 21 years and mean follow-up among survivors was 54 months. Diagnoses were osteosarcoma in nine patients, chondrosarcoma in two, and giant cell tumour in one. Margins were wide in 11 patients and marginal in one. Local recurrence occurred in one patient and distant metastases in three. Primary union was achieved in seven patients. Five developed distal graft-host pseudarthrosis; two underwent revision, of whom one united. Final bone union was achieved in eight patients. Among living patients, mean graft hypertrophy was 34%, mean MSTS score was 25.5/30, active flexion was 80°, and active scapulothoracic abduction was 75%. Cosmetic dissatisfaction was reported by all living patients.
conclusionShoulder arthrodesis with a vascularized fibular graft can provide a stable, functionally useful limb after proximal humeral tumour resection involving the abductor mechanism, although pseudarthrosis and cosmetic dissatisfaction remain important limitations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.